Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis

Kathryn Elizabeth Bollinger, C. Medina, V. L. Perez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.

Original languageEnglish (US)
Pages (from-to)23-25
Number of pages3
JournalOcular Immunology and Inflammation
Volume17
Issue number1
DOIs
StatePublished - Feb 1 2009
Externally publishedYes

Fingerprint

Cutaneous Leukocytoclastic Vasculitis
Scleritis
Inflammation
Photography
Cyclophosphamide
Immunosuppression
Physical Examination
Color
Recurrence
Skin
Therapeutics

Keywords

  • Cutaneous leukocytoclastic vasculitis
  • Episcleritis
  • Ocular inflammation
  • Ocular manifestations vasculitis
  • Ocular vasculitis
  • Systemic vasculitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology

Cite this

Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis. / Bollinger, Kathryn Elizabeth; Medina, C.; Perez, V. L.

In: Ocular Immunology and Inflammation, Vol. 17, No. 1, 01.02.2009, p. 23-25.

Research output: Contribution to journalArticle

@article{6c0da3c92136449e9b0f4888c2a549bf,
title = "Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis",
abstract = "Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.",
keywords = "Cutaneous leukocytoclastic vasculitis, Episcleritis, Ocular inflammation, Ocular manifestations vasculitis, Ocular vasculitis, Systemic vasculitis",
author = "Bollinger, {Kathryn Elizabeth} and C. Medina and Perez, {V. L.}",
year = "2009",
month = "2",
day = "1",
doi = "10.1080/09273940802553287",
language = "English (US)",
volume = "17",
pages = "23--25",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis

AU - Bollinger, Kathryn Elizabeth

AU - Medina, C.

AU - Perez, V. L.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.

AB - Purpose: The authors describe how bilateral episcleritis can be a sign of active systemic disease and can respond to treatment in a patient with cutaneous leukocytoclastic vasculitis. Design: Case report. Methods: Comprehensive ophthalmic and physical examination and color photography were used to monitor inflammation and its response to systemic immunosuppression. Results: Systemic cyclophosphamide caused regression of systemic symptoms, cutaneous lesions, and episcleritis. After an 8-month follow-up, the patient has not had a systemic or ocular recurrence. Conclusion: Episcleritis may be a manifestation of cutaneous leukocytoclastic vasculitis. Careful examination of ocular inflammation is important in monitoring systemic disease and treatment.

KW - Cutaneous leukocytoclastic vasculitis

KW - Episcleritis

KW - Ocular inflammation

KW - Ocular manifestations vasculitis

KW - Ocular vasculitis

KW - Systemic vasculitis

UR - http://www.scopus.com/inward/record.url?scp=67651236373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651236373&partnerID=8YFLogxK

U2 - 10.1080/09273940802553287

DO - 10.1080/09273940802553287

M3 - Article

C2 - 19294569

AN - SCOPUS:67651236373

VL - 17

SP - 23

EP - 25

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 1

ER -